6533b821fe1ef96bd127c21c

RESEARCH PRODUCT

Covid-19 and Congenital Heart Disease: results from a nationwide survey

Francesco BiancoPaolo FerreroGiovanni Di SalvoJolanda SabatinoPaolo GuccioneAurelio SecinaroValentina BucciarelliMassimo ChessaPaolo CilibertiMaria Pia CalabròLilia OretoMartina AvesaniPier Paolo BassareoGiuseppe CalcaterraMaria Giovanna RussoCiro Indolfi

subject

medicine.medical_specialtyHeart diseasePopulationcardiovascular complicationslcsh:Medicine030204 cardiovascular system & hematologyChest painArticle03 medical and health sciences0302 clinical medicineDiabetes mellitusInternal medicinecongenital heart disease COVID-19 cardiovascular complicationsmedicinePalpitations030212 general & internal medicineeducationStrokecardiovascular complicationeducation.field_of_studybusiness.industrylcsh:Rcongenital heart disease; COVID-19; cardiovascular complicationsCOVID-19General Medicinemedicine.diseasecongenital heart diseaseHeart failureCohortmedicine.symptombusiness

description

Background. The pandemic of Novel Coronavirus Disease 2019 (COVID-19) is challenging, given the large number of hospitalized patients. Cardiovascular co-morbidities are linked to a higher mortality risk. Thus, patients with Congenital Heart Disease (CHD) might represent a high-risk population. Nevertheless, no data about them are available, yet. Hence, we conducted a nationwide survey to assess clinical characteristics and outcomes in patients with congenital heart disease affected by COVID-19. Methods and Results. This is a multi-centre, observational, nationwide survey, involving high-volume Italian CHD centres. COVID-19 diagnosis was defined as either &ldquo

yearjournalcountryeditionlanguage
2020-06-08
10.3390/jcm9061774http://hdl.handle.net/11570/3169357